BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8146991)

  • 1. A rapidly fatal case of immune haemolytic anaemia due to cefotetan.
    Peano GM; Menardi G; Quaranta L; Abello P; Landra M; Fenoglio S
    Vox Sang; 1994; 66(1):84-5. PubMed ID: 8146991
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal immune hemolytic anemia due to cefotetan.
    Garratty G; Nance S; Lloyd M; Domen R
    Transfusion; 1992; 32(3):269-71. PubMed ID: 1557811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan-induced haemolytic anaemia. A review of 85 cases.
    Viraraghavan R; Chakravarty AG; Soreth J
    Adverse Drug React Toxicol Rev; 2002; 21(1-2):101-7. PubMed ID: 12140903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.
    Garratty G; Leger RM; Arndt PA
    Am J Obstet Gynecol; 1999 Jul; 181(1):103-4. PubMed ID: 10411803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan-induced hemolysis associated with antibiotic prophylaxis for cesarean delivery.
    Naylor CS; Steele L; Hsi R; Margolin M; Goldfinger D
    Am J Obstet Gynecol; 2000 Jun; 182(6):1427-8. PubMed ID: 10871459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotetan-induced immune hemolytic anemia.
    Chenoweth CE; Judd WJ; Steiner EA; Kauffman CA
    Clin Infect Dis; 1992 Nov; 15(5):863-5. PubMed ID: 1445986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan.
    Gallagher NI; Schergen AK; Sokol-Anderson ML; Sheahan EJ; Chaplin H
    Transfusion; 1992; 32(3):266-8. PubMed ID: 1557810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan.
    Ray EK; Warkentin TE; O'Hoski PL; Gregor P
    Can J Surg; 2000 Dec; 43(6):461-2. PubMed ID: 11129837
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of cefotetan on red blood cells.
    Davenport RD; Judd WJ; Dake LR
    Transfusion; 2004 Jun; 44(6):849-52. PubMed ID: 15157250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotetan-induced hemolytic anemia: a case report and review of the literature.
    Moes GS; MacPherson BR
    Arch Pathol Lab Med; 2000 Sep; 124(9):1344-6. PubMed ID: 10975934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Nicolini A; Perazzo A; Gatto P; Piroddi IM; Barlascini C; Karamichali S; Strada P
    Int J Tuberc Lung Dis; 2016 May; 20(5):704-5. PubMed ID: 27084828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Maclean R; Meiklejohn D; Soutar R
    Br J Haematol; 1996 Mar; 92(3):768-9. PubMed ID: 8616054
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery.
    Shariatmadar S; Storry JR; Sausais L; Reid ME
    Immunohematology; 2004; 20(1):63-6. PubMed ID: 15373671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal acute immune haemolytic anaemia caused by nalidixic acid.
    Tafani O; Mazzoli M; Landini G; Alterini B
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):936-7. PubMed ID: 6811074
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use.
    Ermis B; Caner I; Karacan M; Olgun H
    Thromb Haemost; 2003 Jul; 90(1):158-9. PubMed ID: 12876641
    [No Abstract]   [Full Text] [Related]  

  • 18. Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
    Wilson SE
    J Chemother; 1989 Jul; 1(4 Suppl):820-2. PubMed ID: 16312655
    [No Abstract]   [Full Text] [Related]  

  • 19. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotetan disodium-induced hemolytic anemia.
    Wagner BK; Heaton AH; Flink JR
    Ann Pharmacother; 1992 Feb; 26(2):199-200. PubMed ID: 1554932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.